Hey, this is AUStock_Pedia.
I would like to introduce some Australian companies that may be of some help to your investments.
The company I'm going to introduce is $Creso Pharma(CPH.AU)$.
It went public on 20th October 2016.
[Company Profile]
Creso Pharma Limited is an Australia-based cannabis company.
The Company is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health.
Its cannabidiol (CBD) plant-based nutraceutical products are non-psychoactive, as they only contain trace amounts of tetrahydrocannabinol (THC).
Its product pipeline includes cannaQIX50, cannaQIX10, cannaQIX25 and Medicinal CBD oil and others.
In addition, the Company cultivates and harvests cannabis plants through its wholly owned subsidiary, Mernova Medicinal Inc. (Mernova) and supplies cannabis retail products throughout Canada.
Through its wholly owned, Canada-based psychedelics subsidiary, Halucenex Life Sciences Inc. (Halucenex), it also focused on the development of synthetic and botanical psilocybin treatments for treatment-resistant post-traumatic stress disorder, and other mental health conditions.
[History & Events]
2015: The company was founded by Adam Blumenthal, Miri Halperin Wernli and Boaz Wachtel.
2016: CPH floated on the Australian Securities Exchange (ASX).
2017: Creso first to export medicinal Cannabis from Switzerland.
2018: Commercialisation agreement signed for UK launch of cannaQIX.
2019: Creso signed supply agreement with TerrAscend Canada.
2022: Creso Pharma acquired Sierra Sage Herbs (SSH).
2022: Creso Pharma Ltd has signed a non-binding term sheet for the acquisition of Health House International (HHI) Ltd.
[Main Business Segments]
[Net Income & Total Revenue]
[Competitors]
Canada House (formerly known as Abba Medix Group Inc.)
$Jupiter Wellness, Inc.(JUPW)$
CC-Pharma
Comments